The report “Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Dallas, TX -- (SBWIRE) -- 06/03/2015 -- Browse 77 market data tables and 73 figures spread through 216 pages and in-depth TOC on "Defibrillators Market"
Early buyers will receive 10% customization on this report.
This report studies the global defibrillators market over the forecast period of 2014 to 2019. The market is expected to reach $12.9 billion by 2019 at CAGR of 6.9% from 2014 to 2019.
Based on products, the defibrillators market is classified into two major segments, namely, implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICD segment is further segmented into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). T-ICDs are further segmented into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-D). External defibrillators are segmented into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=549
Based on end users, the defibrillators market is categorized into five major segments, namely, hospitals, prehospitals, public access markets, alternate care markets, and homes.
A number of factors such as the development of technologically advanced defibrillators; rapid growth in aging population with high risk of target diseases; rising incidences of cardiovascular diseases; growing focus of public and private organizations and key market players towards public access defibrillators; and increasing number of training and awareness programs across the globe are driving the growth of the global defibrillators market. However, factors such as the lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restricting the growth of the market.
In 2014, North America accounted for the largest share of the market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of ~7.1% from 2014 to 2019. The high growth in this region can be attributed to the rapid growth in the aging population, growing focus of multinational companies on emerging markets, improving healthcare infrastructure, and huge burden of cardiovascular diseases in this region.
You can speak To Research Analyst to know more about Report:
Some of the major players in the global defibrillators market are Medtronic, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Sorin Group (Italy), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Nihon Kohden Corporation (Japan), and HeartSine Technologies, Inc. (U.S.).
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets